Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CLK4 | Q9HAZ1 | 3/20 | 0.45 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.45 |
| ▸ | PGR | P06401 | 6/20 | 0.37 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.37 |
| ▸ | RARA | P10276 | 1/20 | 0.36 |
| ▸ | RARB | P10826 | 1/20 | 0.36 |
| ▸ | RARG | P13631 | 1/20 | 0.36 |
| ▸ | PDK2 | Q15119 | 5/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14508268 | 0.98 | CLK4 (0.44) | CLK4DYRK1APGRADRB2RARA | |
| SCHEMBL14508279 | 0.98 | CLK4 (0.44) | CLK4DYRK1APGRADRB2RARA | |
| SCHEMBL14508219 | 0.95 | CLK4 (0.41) | CLK4DYRK1APGRRARARARB | |
| SCHEMBL14508213 | 0.95 | CLK4 (0.41) | CLK4DYRK1APGRRARARARB | |
| SCHEMBL14508217 | 0.94 | PDK2 (0.41) | CLK4DYRK1APDK2 | |
| SCHEMBL20359400 | 0.94 | PDK2 (0.41) | CLK4DYRK1APDK2 | |
| SCHEMBL14508227 | 0.94 | PDK2 (0.41) | CLK4DYRK1APDK2 | |
| SCHEMBL13388771 | 0.93 | CLK4 (0.42) | CLK4DYRK1AADRB2PDK2CYP2A6 | |
| SCHEMBL14508200 | 0.92 | PDK2 (0.40) | CLK4DYRK1APGRRARARARB | |
| SCHEMBL14508294 | 0.91 | CLK4 (0.39) | CLK4DYRK1APGRADRB2RARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070122652-A1 | Compound and organic electroluminescent device using same | CANON KABUSHIKI KAISHA (JP) | 2007-05-31 | — | — | US | disclosed |
| US-20070122652-A1 | Compound and organic electroluminescent device using same | CANON KABUSHIKI KAISHA (JP) | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070122652-A1 | Compound and organic electroluminescent device using same | OR10J3, LEF1, RPL19 | CLK4 3063/4885DYRK1A 4071/4885PGR 756/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.